| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Multiple Pulmonary Nodules | 7 | 2019 | 115 | 2.08 | Why? |
| Tomography, X-Ray Computed | 45 | 2021 | 25144 | 1.96 | Why? |
| Solitary Pulmonary Nodule | 6 | 2019 | 83 | 1.86 | Why? |
| Lung Neoplasms | 21 | 2021 | 3228 | 1.79 | Why? |
| Lung Diseases, Interstitial | 8 | 2018 | 1476 | 1.60 | Why? |
| Idiopathic Pulmonary Fibrosis | 10 | 2019 | 595 | 1.55 | Why? |
| Early Detection of Cancer | 10 | 2021 | 1956 | 0.82 | Why? |
| Neoplasms, Radiation-Induced | 1 | 2020 | 60 | 0.81 | Why? |
| Lung | 30 | 2021 | 31049 | 0.81 | Why? |
| Radiometry | 1 | 2020 | 136 | 0.81 | Why? |
| Radiographic Image Interpretation, Computer-Assisted | 6 | 2020 | 869 | 0.78 | Why? |
| Incidental Findings | 3 | 2021 | 487 | 0.77 | Why? |
| Aortography | 2 | 2019 | 60 | 0.73 | Why? |
| Radiologists | 4 | 2021 | 873 | 0.71 | Why? |
| Parenchymal Tissue | 1 | 2017 | 61 | 0.67 | Why? |
| Vascular Calcification | 3 | 2021 | 396 | 0.65 | Why? |
| Radiation Dosage | 3 | 2020 | 585 | 0.65 | Why? |
| Pulmonary Fibrosis | 4 | 2020 | 1068 | 0.61 | Why? |
| Radiography | 2 | 2021 | 1576 | 0.60 | Why? |
| Computed Tomography Angiography | 4 | 2021 | 2153 | 0.55 | Why? |
| Sarcoidosis, Pulmonary | 3 | 2018 | 91 | 0.48 | Why? |
| Image Interpretation, Computer-Assisted | 1 | 2018 | 665 | 0.45 | Why? |
| Radiography, Thoracic | 10 | 2021 | 5486 | 0.44 | Why? |
| Emphysema | 1 | 2011 | 52 | 0.44 | Why? |
| Observer Variation | 5 | 2021 | 622 | 0.44 | Why? |
| Pulmonary Medicine | 1 | 2017 | 706 | 0.43 | Why? |
| Thorax | 1 | 2020 | 1873 | 0.42 | Why? |
| Scleroderma, Systemic | 1 | 2017 | 583 | 0.42 | Why? |
| Cardiovascular System | 1 | 2018 | 750 | 0.41 | Why? |
| Forced Expiratory Volume | 1 | 2011 | 632 | 0.37 | Why? |
| Mass Screening | 5 | 2018 | 8005 | 0.37 | Why? |
| Lung Diseases | 2 | 2020 | 2361 | 0.35 | Why? |
| Cryosurgery | 2 | 2018 | 57 | 0.33 | Why? |
| Radiology | 1 | 2017 | 1199 | 0.31 | Why? |
| Respiratory Sounds | 2 | 2019 | 294 | 0.30 | Why? |
| Triage | 3 | 2021 | 7151 | 0.30 | Why? |
| Italy | 17 | 2021 | 38444 | 0.29 | Why? |
| Embolization, Therapeutic | 2 | 2019 | 269 | 0.28 | Why? |
| Pulmonary Emphysema | 2 | 2017 | 122 | 0.26 | Why? |
| Biopsy | 6 | 2018 | 2811 | 0.26 | Why? |
| Occupational Health | 1 | 2020 | 3965 | 0.26 | Why? |
| Aorta, Thoracic | 3 | 2021 | 271 | 0.23 | Why? |
| Ultrasonography | 5 | 2021 | 4409 | 0.23 | Why? |
| Reproducibility of Results | 7 | 2020 | 11304 | 0.22 | Why? |
| Dilatation, Pathologic | 1 | 2021 | 78 | 0.22 | Why? |
| Humans | 72 | 2021 | 930598 | 0.22 | Why? |
| Auscultation | 2 | 2019 | 115 | 0.21 | Why? |
| Bed Conversion | 1 | 2020 | 236 | 0.20 | Why? |
| Predictive Value of Tests | 7 | 2021 | 9537 | 0.20 | Why? |
| Pulmonary Veins | 1 | 2021 | 146 | 0.19 | Why? |
| Vascular Fistula | 1 | 2019 | 22 | 0.19 | Why? |
| Asthma | 1 | 2018 | 4383 | 0.19 | Why? |
| Acid Anhydride Hydrolases | 1 | 2018 | 16 | 0.19 | Why? |
| Duodenal Diseases | 1 | 2019 | 30 | 0.19 | Why? |
| Phantoms, Imaging | 1 | 2019 | 146 | 0.19 | Why? |
| Intestinal Fistula | 1 | 2019 | 43 | 0.19 | Why? |
| Renal Artery | 1 | 2019 | 66 | 0.18 | Why? |
| Thrombosis | 1 | 2020 | 7504 | 0.18 | Why? |
| Disease Outbreaks | 4 | 2020 | 27595 | 0.18 | Why? |
| Blood Vessel Prosthesis | 1 | 2019 | 115 | 0.18 | Why? |
| Smoking | 1 | 2011 | 3358 | 0.18 | Why? |
| Aortic Diseases | 2 | 2021 | 362 | 0.17 | Why? |
| Liver Cirrhosis, Biliary | 1 | 2017 | 42 | 0.17 | Why? |
| Multidetector Computed Tomography | 1 | 2021 | 307 | 0.17 | Why? |
| Tuberous Sclerosis | 1 | 2017 | 63 | 0.17 | Why? |
| Aorta, Abdominal | 1 | 2017 | 50 | 0.17 | Why? |
| Bronchoscopy | 4 | 2018 | 991 | 0.17 | Why? |
| Pleural Neoplasms | 1 | 2017 | 71 | 0.17 | Why? |
| Bronchial Arteries | 1 | 2016 | 30 | 0.17 | Why? |
| Lymphangioleiomyomatosis | 1 | 2017 | 39 | 0.17 | Why? |
| Betacoronavirus | 11 | 2020 | 204454 | 0.17 | Why? |
| Biopsy, Large-Core Needle | 1 | 2017 | 81 | 0.17 | Why? |
| Male | 36 | 2021 | 367725 | 0.17 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 9706 | 0.16 | Why? |
| Mesothelioma | 1 | 2017 | 76 | 0.16 | Why? |
| Pleural Diseases | 1 | 2017 | 68 | 0.16 | Why? |
| Tomography, Spiral Computed | 1 | 2017 | 109 | 0.16 | Why? |
| Aged | 26 | 2021 | 215776 | 0.16 | Why? |
| Coronary Artery Disease | 1 | 2011 | 2570 | 0.16 | Why? |
| Disease Progression | 5 | 2020 | 13580 | 0.16 | Why? |
| Female | 35 | 2021 | 380317 | 0.16 | Why? |
| Middle Aged | 28 | 2021 | 270681 | 0.16 | Why? |
| Signal-To-Noise Ratio | 1 | 2017 | 217 | 0.16 | Why? |
| Pericardium | 1 | 2019 | 228 | 0.16 | Why? |
| Biopsy, Fine-Needle | 1 | 2017 | 274 | 0.15 | Why? |
| Breath Tests | 1 | 2019 | 338 | 0.15 | Why? |
| Blood Vessel Prosthesis Implantation | 1 | 2019 | 226 | 0.15 | Why? |
| Pneumonia, Viral | 13 | 2021 | 243684 | 0.15 | Why? |
| Prognosis | 7 | 2020 | 32490 | 0.15 | Why? |
| Coronavirus Infections | 12 | 2020 | 253789 | 0.15 | Why? |
| Preventive Health Services | 1 | 2021 | 501 | 0.14 | Why? |
| Lymphadenopathy | 1 | 2021 | 444 | 0.14 | Why? |
| Pleural Effusion | 1 | 2021 | 680 | 0.14 | Why? |
| Sarcoidosis | 1 | 2018 | 271 | 0.14 | Why? |
| Hemoptysis | 1 | 2016 | 172 | 0.14 | Why? |
| Lymph Nodes | 1 | 2021 | 1060 | 0.13 | Why? |
| Pulmonary Artery | 1 | 2021 | 803 | 0.13 | Why? |
| Smokers | 1 | 2019 | 550 | 0.13 | Why? |
| Research Report | 1 | 2017 | 376 | 0.13 | Why? |
| Algorithms | 3 | 2020 | 7346 | 0.13 | Why? |
| Adipose Tissue | 1 | 2019 | 612 | 0.13 | Why? |
| Sensitivity and Specificity | 5 | 2021 | 22971 | 0.13 | Why? |
| Hepatitis, Autoimmune | 1 | 2017 | 254 | 0.13 | Why? |
| Risk Assessment | 4 | 2020 | 25439 | 0.12 | Why? |
| Delphi Technique | 1 | 2017 | 1257 | 0.12 | Why? |
| Positron Emission Tomography Computed Tomography | 2 | 2020 | 1458 | 0.12 | Why? |
| Neoplasm Proteins | 1 | 2018 | 501 | 0.12 | Why? |
| Diagnosis, Computer-Assisted | 1 | 2018 | 436 | 0.12 | Why? |
| Software | 2 | 2020 | 2501 | 0.12 | Why? |
| Respiratory Tract Diseases | 1 | 2020 | 1061 | 0.11 | Why? |
| Magnetic Resonance Imaging | 2 | 2017 | 6551 | 0.11 | Why? |
| Carcinoma, Renal Cell | 1 | 2018 | 545 | 0.11 | Why? |
| Stents | 1 | 2019 | 916 | 0.11 | Why? |
| Models, Statistical | 2 | 2020 | 5312 | 0.11 | Why? |
| Health Care Surveys | 1 | 2021 | 2942 | 0.11 | Why? |
| Hypertension, Pulmonary | 2 | 2018 | 970 | 0.11 | Why? |
| Diagnosis, Differential | 4 | 2020 | 7220 | 0.11 | Why? |
| Retrospective Studies | 11 | 2021 | 105322 | 0.10 | Why? |
| Adenocarcinoma | 1 | 2017 | 651 | 0.10 | Why? |
| Aged, 80 and over | 8 | 2021 | 88759 | 0.10 | Why? |
| Kidney Neoplasms | 1 | 2018 | 832 | 0.10 | Why? |
| Pulmonary Disease, Chronic Obstructive | 1 | 2007 | 3832 | 0.10 | Why? |
| Statistics as Topic | 1 | 2011 | 370 | 0.09 | Why? |
| Endovascular Procedures | 1 | 2019 | 1302 | 0.09 | Why? |
| Prospective Studies | 6 | 2019 | 43301 | 0.09 | Why? |
| Patient Care Management | 1 | 2020 | 1514 | 0.09 | Why? |
| Practice Guidelines as Topic | 5 | 2021 | 15421 | 0.09 | Why? |
| Carcinoma, Squamous Cell | 1 | 2017 | 902 | 0.09 | Why? |
| Image Processing, Computer-Assisted | 1 | 2017 | 1383 | 0.09 | Why? |
| Radiology Department, Hospital | 3 | 2021 | 805 | 0.09 | Why? |
| Regression Analysis | 1 | 2015 | 2484 | 0.09 | Why? |
| Hospitals, University | 1 | 2020 | 4173 | 0.08 | Why? |
| Cohort Studies | 4 | 2020 | 36005 | 0.08 | Why? |
| Pandemics | 14 | 2021 | 389249 | 0.08 | Why? |
| Image-Guided Biopsy | 2 | 2019 | 185 | 0.08 | Why? |
| Europe | 3 | 2020 | 12702 | 0.08 | Why? |
| Survival Analysis | 3 | 2018 | 7592 | 0.08 | Why? |
| Proportional Hazards Models | 1 | 2018 | 6543 | 0.08 | Why? |
| Adult | 10 | 2021 | 244371 | 0.07 | Why? |
| Survival Rate | 3 | 2017 | 9206 | 0.07 | Why? |
| Arthritis, Rheumatoid | 1 | 2018 | 2043 | 0.07 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 5993 | 0.07 | Why? |
| Sex Factors | 1 | 2020 | 11014 | 0.06 | Why? |
| Antineoplastic Agents | 1 | 2018 | 3550 | 0.06 | Why? |
| Neoplasm Staging | 2 | 2019 | 1999 | 0.06 | Why? |
| Gallium Isotopes | 1 | 2020 | 42 | 0.05 | Why? |
| Gallium Radioisotopes | 1 | 2020 | 90 | 0.05 | Why? |
| Practice Patterns, Physicians' | 1 | 2019 | 4927 | 0.05 | Why? |
| Pneumonia | 1 | 2020 | 5652 | 0.05 | Why? |
| Sulfur | 1 | 2019 | 21 | 0.05 | Why? |
| Societies, Medical | 3 | 2021 | 6907 | 0.05 | Why? |
| Longitudinal Studies | 1 | 2015 | 9893 | 0.05 | Why? |
| Sound | 1 | 2019 | 43 | 0.05 | Why? |
| Loss of Heterozygosity | 1 | 2018 | 14 | 0.05 | Why? |
| Models, Theoretical | 1 | 2017 | 6659 | 0.05 | Why? |
| DNA Repair | 1 | 2018 | 114 | 0.04 | Why? |
| X-Rays | 1 | 2020 | 492 | 0.04 | Why? |
| Radionuclide Imaging | 1 | 2019 | 184 | 0.04 | Why? |
| Asbestos | 1 | 2017 | 45 | 0.04 | Why? |
| Organometallic Compounds | 1 | 2020 | 206 | 0.04 | Why? |
| Recurrence | 2 | 2019 | 3675 | 0.04 | Why? |
| Disease Transmission, Infectious | 1 | 2021 | 9044 | 0.04 | Why? |
| Societies | 1 | 2017 | 95 | 0.04 | Why? |
| Matrix Metalloproteinase 7 | 1 | 2016 | 21 | 0.04 | Why? |
| Tumor Suppressor Proteins | 1 | 2018 | 165 | 0.04 | Why? |
| Risk Factors | 6 | 2019 | 71621 | 0.04 | Why? |
| ROC Curve | 2 | 2020 | 6024 | 0.04 | Why? |
| Hyperplasia | 1 | 2017 | 204 | 0.04 | Why? |
| Hypercholesterolemia | 1 | 2019 | 175 | 0.04 | Why? |
| Pilot Projects | 2 | 2019 | 5182 | 0.04 | Why? |
| Radiology, Interventional | 1 | 2021 | 398 | 0.04 | Why? |
| Guideline Adherence | 2 | 2020 | 2309 | 0.04 | Why? |
| Reoperation | 1 | 2019 | 544 | 0.04 | Why? |
| Prosthesis Design | 1 | 2019 | 594 | 0.04 | Why? |
| Medical Overuse | 1 | 2018 | 146 | 0.04 | Why? |
| Osteopontin | 1 | 2016 | 96 | 0.04 | Why? |
| Consensus | 2 | 2021 | 6345 | 0.04 | Why? |
| Pulmonary Surfactant-Associated Protein D | 1 | 2016 | 129 | 0.04 | Why? |
| Emergency Service, Hospital | 4 | 2020 | 14232 | 0.04 | Why? |
| Radiopharmaceuticals | 1 | 2020 | 763 | 0.04 | Why? |
| Prevalence | 2 | 2020 | 25773 | 0.04 | Why? |
| Adaptor Proteins, Signal Transducing | 1 | 2018 | 502 | 0.03 | Why? |
| Aortic Valve | 1 | 2021 | 664 | 0.03 | Why? |
| Age Factors | 1 | 2015 | 21039 | 0.03 | Why? |
| Contrast Media | 1 | 2020 | 1011 | 0.03 | Why? |
| Video Recording | 1 | 2020 | 786 | 0.03 | Why? |
| Probability | 1 | 2017 | 923 | 0.03 | Why? |
| Coronary Vessels | 1 | 2021 | 914 | 0.03 | Why? |
| Hospital Units | 1 | 2020 | 1017 | 0.03 | Why? |
| Administration, Inhalation | 1 | 2019 | 1647 | 0.03 | Why? |
| Pulmonary Aspergillosis | 1 | 2018 | 408 | 0.03 | Why? |
| Fluorodeoxyglucose F18 | 1 | 2020 | 1153 | 0.03 | Why? |
| Program Evaluation | 1 | 2021 | 1929 | 0.03 | Why? |
| Hospital Bed Capacity | 1 | 2020 | 1300 | 0.03 | Why? |
| Nitric Oxide | 1 | 2019 | 769 | 0.03 | Why? |
| Incidence | 3 | 2019 | 25622 | 0.03 | Why? |
| Neoplasms | 1 | 2020 | 17251 | 0.03 | Why? |
| Feasibility Studies | 1 | 2021 | 3467 | 0.03 | Why? |
| Membrane Glycoproteins | 1 | 2020 | 2273 | 0.03 | Why? |
| Severity of Illness Index | 4 | 2021 | 48226 | 0.03 | Why? |
| Early Diagnosis | 1 | 2020 | 2443 | 0.03 | Why? |
| Organizational Innovation | 1 | 2021 | 2468 | 0.03 | Why? |
| Sex Distribution | 1 | 2018 | 2083 | 0.03 | Why? |
| Workflow | 1 | 2020 | 2373 | 0.03 | Why? |
| Respiratory Function Tests | 1 | 2017 | 1755 | 0.03 | Why? |
| Communicable Disease Control | 1 | 2020 | 29620 | 0.03 | Why? |
| Adolescent | 1 | 2020 | 86841 | 0.03 | Why? |
| Health Personnel | 1 | 2020 | 29646 | 0.02 | Why? |
| Alveolar Epithelial Cells | 1 | 2017 | 1445 | 0.02 | Why? |
| Fatal Outcome | 1 | 2019 | 3438 | 0.02 | Why? |
| Diagnostic Tests, Routine | 1 | 2020 | 2643 | 0.02 | Why? |
| Monitoring, Physiologic | 1 | 2019 | 1956 | 0.02 | Why? |
| Heart Defects, Congenital | 1 | 2016 | 933 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2018 | 5440 | 0.02 | Why? |
| Comorbidity | 1 | 2011 | 34796 | 0.02 | Why? |
| Treatment Outcome | 3 | 2019 | 51732 | 0.02 | Why? |
| Point-of-Care Testing | 1 | 2020 | 2782 | 0.02 | Why? |
| Fatigue | 1 | 2018 | 2479 | 0.02 | Why? |
| International Cooperation | 1 | 2020 | 3436 | 0.02 | Why? |
| Double-Blind Method | 1 | 2017 | 5988 | 0.02 | Why? |
| Body Mass Index | 1 | 2019 | 4306 | 0.02 | Why? |
| Biomarkers | 2 | 2019 | 23361 | 0.02 | Why? |
| Cause of Death | 1 | 2019 | 4823 | 0.02 | Why? |
| Forecasting | 1 | 2019 | 4492 | 0.02 | Why? |
| Intensive Care Units | 2 | 2020 | 29594 | 0.02 | Why? |
| Logistic Models | 1 | 2018 | 9089 | 0.02 | Why? |
| Patient Admission | 1 | 2020 | 5250 | 0.02 | Why? |
| Odds Ratio | 1 | 2012 | 5861 | 0.01 | Why? |
| Occupational Exposure | 1 | 2017 | 4742 | 0.01 | Why? |
| Hospitalization | 2 | 2020 | 54280 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2017 | 17020 | 0.01 | Why? |
| Case-Control Studies | 1 | 2017 | 17671 | 0.01 | Why? |
| Hypertension | 1 | 2019 | 8895 | 0.01 | Why? |
| Diabetes Mellitus | 1 | 2019 | 8207 | 0.01 | Why? |
| Global Health | 1 | 2020 | 13911 | 0.01 | Why? |
| Time Factors | 1 | 2019 | 31397 | 0.01 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.01 | Why? |
| Public Health | 1 | 2020 | 16359 | 0.01 | Why? |
| Cardiovascular Diseases | 1 | 2019 | 11497 | 0.01 | Why? |
| RNA, Viral | 1 | 2021 | 32276 | 0.01 | Why? |
| Infection Control | 1 | 2021 | 23131 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2019 | 43792 | 0.01 | Why? |